版本:
中国

BRIEF-Reata Pharmaceuticals says data from catalyst are expected to be available during first half of 2018

Oct 6 Reata Pharmaceuticals Inc :

* PAH patients and reports positive interim data from CTD-PAH patients in phase 2 lariat trial

* Data from catalyst are expected to be available during first half of 2018 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐